Literature DB >> 5554841

Ascites and renal failure in liver disease: principles of management. Weekly clinical conference of the Section of Gastroenterology of the University of Michigan.

K S Henley.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 5554841     DOI: 10.1007/bf02235217

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


× No keyword cloud information.
  8 in total

1.  Long-term medical management and complications of 'resistant' ascites.

Authors:  W H SUMMERSKILL; B F CLOWDUS; J W ROSEVEAR
Journal:  Gut       Date:  1961-12       Impact factor: 23.059

2.  Diuretic and steroid therapy in liver disease.

Authors:  T C CHALMERS; R S MORRISON
Journal:  Prog Liver Dis       Date:  1961

3.  [The effects of changes of the sodium chloride content of the incubation medium on the urea synthesis of the liver. (A contribution to the pathogenesis of extrarenal azotemias)].

Authors:  G REISSLAND
Journal:  Klin Wochenschr       Date:  1961-04-15

4.  The effect of diuretics on portal venous pressure.

Authors:  M ATKINSON
Journal:  Lancet       Date:  1959-11-14       Impact factor: 79.321

5.  Observations on the influence of medical therapy on portal hypertension in hepatic cirrhosis.

Authors:  C M LEEVY; M ZINKE; J BABER; W Y CHEY
Journal:  Ann Intern Med       Date:  1958-10       Impact factor: 25.391

6.  On the Absorption of Fluids from the Connective Tissue Spaces.

Authors:  E H Starling
Journal:  J Physiol       Date:  1896-05-05       Impact factor: 5.182

7.  Compartmentalization of ascites and edema in patients with hepatic cirrhosis.

Authors:  L Shear; S Ching; G J Gabuzda
Journal:  N Engl J Med       Date:  1970-06-18       Impact factor: 91.245

8.  Effect of hypokalemia on the reductive amination of alpha-ketoglutarate by mitochondria from normal and cirrhotic rat liver.

Authors:  J J Gumucio; E G Laughrey; K S Henley
Journal:  Gastroenterology       Date:  1969-04       Impact factor: 22.682

  8 in total
  1 in total

1.  Pharmacokinetics of furosemide in patients with hepatic cirrhosis.

Authors:  G González; A Arancibia; M I Rivas; P Caro; C Antezana
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.